1244 — 3D Medicines Cashflow Statement
0.000.00%
Last trade - 00:00
- HK$1.61bn
- HK$762.43m
- CNY634.95m
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | — |
Source: | PROSPECTUS | PROSPECTUS | ARS | |
Standards: | IFRS | IFRS | — | — |
Status: | Final | Final | Final | fx Preliminary |
Net Income/Starting Line | -635 | -1,462 | -1,052 | — |
Depreciation | ||||
Amortisation | ||||
Non-Cash Items | 332 | 1,112 | 759 | — |
Unusual Items | ||||
Other Non-Cash Items | ||||
Changes in Working Capital | 21.8 | -39.9 | -7.35 | — |
Change in Accounts Receivable | ||||
Change in Inventories | ||||
Change in Prepaid Expenses | ||||
Change in Other Assets | ||||
Change in Accounts Payable | ||||
Cash from Operating Activities | -278 | -377 | -279 | — |
Capital Expenditures | -11.1 | -44.9 | -54 | — |
Purchase of Fixed Assets | ||||
Purchase / Acquisition of Intangibles | ||||
Other Investing Cash Flow Items | -9.33 | -54 | -188 | — |
Acquisition of Business | ||||
Sale of Fixed Assets | ||||
Sale/Maturity of Investment | ||||
Purchase of Investments | ||||
Other Investing Cash Flow | ||||
Cash from Investing Activities | -20.5 | -98.9 | -242 | — |
Financing Cash Flow Items | -18.5 | 309 | -24.2 | — |
Other Financing Cash Flow | ||||
Net Issuance / Retirement of Stock | ||||
Net Issuance / Retirement of Debt | ||||
Cash from Financing Activities | 607 | 840 | 408 | — |
Foreign Exchange Effects | ||||
Beginning Cash Balance | ||||
Ending Cash Balance | ||||
Net Change in Cash | 302 | 360 | -77.6 | — |